27.04.2018 10:30-10:45 Opening and welcome Sala B Moderation: S. Rauh, J. Douillard ; Esch Sur Alzette, LU, Lugano - Viganello, CEDEX/CH 10:30-10:45 Welcome to the Symposium S. Rauh 1, J. Douillard 2 ; 1 Esch Sur Alzette, LU, 2 Lugano - Viganello, CEDEX/CH 10:45-12:15 Standards in NSCLC in 2018 Sala B Moderation: M. Garassino, S. Rauh ; Milan, IT, Esch Sur Alzette, LU 10:45-11:05 Standards of care in locally advanced, unresectable NSCLC M. Garassino, Milan, IT 11:05-11:10 Case presentation and discussion: Locally advanced unresectable NSCLC - immuno following radio-chemo 11:10-11:25 Discussion M. Garassino 1, S. Rauh 2 ; 1 Milan, IT, 2 Esch Sur Alzette, LU 11:25-11:30 Case presentation and discussion: Adjuvant treatment oncogene-addicted NSCLC anti EGFR / same for ALK, Ros, etc. 11:30-11:45 Discussion M. Garassino 1, S. Rauh 2 ; 1 Milan, IT, 2 Esch Sur Alzette, LU 11:45-11:50 Case presentation and discussion: Metastatic oncogene addicted, PD-L1 post: treatment schedule? 11:50-12:05 Discussion M. Garassino 1, S. Rauh 2 ; 1 Milan, IT, 2 Esch Sur Alzette, LU 12:05-12:15 Conclusion and future outlook M. Garassino, Milan, IT 12:15-13:15 Lunch Sala B
13:15-13:45 Keynote lecture Sala B Moderation: 13:15-13:45 Immunotherapy in 2018: Hope, hype or breakthrough: An overview of use and benefit in current knowledge 13:45-15:15 Standards in melanoma in 2018 Sala B Moderation: R. Curca, O. Michielin ; Alba Iulia, RO, Lausanne, CH 13:45-13:50 Introduction and overview of the most relevant, practice-changing abstracts in 2017 R. Curca, Alba Iulia, RO 13:50-14:10 Standards of care in metastatic melanoma O. Michielin, Lausanne, CH 14:10-14:20 Case presentation: BRAF WT patient R. Curca, Alba Iulia, RO 14:20-14:40 Discussion R. Curca 1, O. Michielin 2 ; 1 Alba Iulia, RO, 2 Lausanne, CH 14:40-14:50 Case presentation: BRAF mutant patient R. Curca, Alba Iulia, RO 14:50-15:10 Discussion R. Curca 1, O. Michielin 2 ; 1 Alba Iulia, RO, 2 Lausanne, CH 15:10-15:15 Conclusions and future outlook O. Michielin, Lausanne, CH 15:15-15:45 Coffee break Sala B
15:45-17:30 Standards in colorectal cancer in 2018 Sala B Moderation: M. Karamouzis, D. Arnold ; Kolonaki, Athens/GR, Hamburg, DE 15:45-15:55 Introduction M. Karamouzis 1, D. Arnold 2 ; 1 Kolonaki, GR, 2 Lisbon, PT 15:55-16:20 Are we ready to change the duration of adjuvant chemotherapy in 2018? Adjuvant treatment of rectal cancer what s new in 2018? D. Arnold, Hamburg, DE 16:20-16:45 Metastatic colorectal cancer - what s new in 2018? M. Karamouzis, Kolonaki, GR 16:45-16:50 Case presentation: Early stage disease M. Karamouzis, Kolonaki, GR 16:50-17:05 Discussion D. Arnold, Hamburg, DE 17:05-17:10 Case presentation: Metastatic stage disease D. Arnold, Lisbon, PT 17:10-17:25 Discussion M. Karamouzis, Kolonaki, Athens/GR 17:25-17:30 Conclusions and future outlook D. Arnold 1, M. Karamouzis 2 ; 1 Hamburg, DE, 2 Kolonaki, Athens/GR
17:30-19:00 Standards in non-hodgkin's lymphoma in 2018 Sala B Moderation: R. Eckert, M. Ghielmini ; Esslingen, DE, Bellinzona, CH 17:30-17:35 Introduction 17:35-17:55 Standards of care in NHL M. Ghielmini, Bellinzona, CH 17:55-18:05 Case presentation 1 18:05-18:25 Discussion R. Eckert 1, M. Ghielmini 2 ; 1 Esslingen, DE, 2 Bellinzona, CH 18:25-18:35 Case presentation 2 18:35-18:55 Discussion R. Eckert 1, M. Ghielmini 2 ; 1 Esslingen, DE, 2 Bellinzona, CH 18:55-19:00 Conclusions and future outlook M. Ghielmini, Bellinzona, CH 28.04.2018
09:00-10:30 Standards in locally advanced, non-metastatic upper GI cancers (Gastroesophageal) in 2018 Sala B Moderation: G. Lakatos, M. Ducreux ; Budapest, HU, Villejuif, CEDEX/FR 09:00-09:05 Introduction G. Lakatos, Budapest, HU 09:05-09:25 Standards of care in upper GI cancers M. Ducreux, Villejuif, CEDEX/FR 09:25-09:35 Case presentation: Locally advanced oesophageal cancer G. Lakatos, Budapest, HU 09:35-09:55 Discussion G. Lakatos 1, M. Ducreux 2 ; 1 Budapest, HU, 2 Villejuif, CEDEX/FR 09:55-10:05 Case presentation: Locally advanced gastric cancer G. Lakatos, Budapest, HU 10:05-10:25 Discussion G. Lakatos 1, M. Ducreux 2 ; 1 Budapest, HU, 2 Villejuif, CEDEX/FR 10:25-10:30 Conclusions and future outlook M. Ducreux, Villejuif, CEDEX/FR 10:30-11:00 Coffee break Sala B
11:00-12:30 Standards in metastatic prostate cancer in 2018 Sala B Moderation: A. Froebe, M. De Santis ; Zagreb, HR, Berlin, DE 11:00-11:05 Introduction A. Froebe, Zagreb, HR 11:05-11:25 Standards of care in metastatic prostate cancer M. De Santis, Coventry, GB 11:25-11:35 Case presentation: Metastatic prostate cancer upon initial diagnosis: CHAARTED, etc. A. Froebe, Zagreb, HR 11:35-11:55 Discussion A. Froebe 1, M. De Santis 2 ; 1 Zagreb, HR, 2 Coventry, GB 11:55-12:05 Case presentation: CRPC incl. therapeutic use of isotopes in metastatic prostate cancer A. Froebe, Zagreb, HR 12:05-12:25 Discussion A. Froebe 1, M. De Santis 2 ; 1 Zagreb, HR, 2 Coventry, GB 12:25-12:30 Conclusions and future outlook M. De Santis, Berlin, DE 12:30-13:30 Lunch Sala B 13:30-14:00 Keynote lecture: San Salvatore award lecture Sala B Moderation: R.A. Stahel, S. Rauh ; Zürich, CH, Esch Sur Alzette, LU 13:30-14:00 To be announced
14:00-15:30 Standards in bladder and kidney metastatic cancers in 2018 Sala B Moderation: J. Molitor, Y. Vano; Paris, FR 14:00-14:05 Introduction J. Molitor, Paris, FR 14:05-14:25 Standards of care in bladder and kidney cancer Y. Vano, Paris, FR 14:25-14:35 Case presentation: Immunotherapy in kidney cancer: When? J. Molitor, Paris, FR 14:35-14:55 Discussion J. Molitor, Y. Vano; Paris, FR 14:55-15:05 Case presentation: Second-line treatment for bladder cancer J. Molitor, Paris, FR 15:05-15:25 Discussion Y. Vano, J. Molitor; Paris, FR 15:25-15:30 Conclusions and future outlook Y. Vano, Paris, FR 15:30-16:00 Coffee break Sala B
16:00-17:30 Standards in breast cancer in 2018 Sala B Moderation: S. Braga, A. Gennari ; Lisbon, PT, Genova, IT 16:00-16:20 Standards of care in neo-adjuvant /adjuvant breast cancer A. Gennari, Genova, IT 16:20-16:30 Case presentations: An (elderly) patient with HER2 neo adjuvant - adjuvant treatment S. Braga, Lisbon, PT 16:30-16:45 Discussion S. Braga 1, A. Gennari 2 ; 1 Lisbon, PT, 2 Genova, IT 16:45-17:05 Standards of care in metastatic breast cancer, including CDK4 inhibitors and impact on treatment A. Gennari, Genova, IT 17:05-17:15 Case presentation: Who benefits from CDK4 inhibitors? Toxicity issues S. Braga, Lisbon, PT 17:15-17:30 Discussion and future outlook S. Braga 1, A. Gennari 2 ; 1 Lisbon, PT, 2 Genova, IT 17:30-18:00 Workshop: Managing survivorship care Sala B Moderation: 17:30-17:50 ESMO guidelines and survivorship guide 17:50-18:00 Interactive discussion 18:00-19:00 Networking Foyer 29.04.2018
09:00-10:30 Standards in multiple myeloma in 2018 Sala B Moderation: R. Eckert, J. Harousseau ; Esslingen, DE, Nantes, CEDEX 1/FR 09:00-09:05 Introduction (including overview of the 4 most relevant, practice-changing abstracts in 2017) 09:05-09:35 Standards of care in multiple myeloma J. Harousseau, Nantes, CEDEX 1/FR 09:35-09:45 Case presentation 1 09:45-10:00 Discussion R. Eckert 1, J. Harousseau 2 ; 1 Esslingen, DE, 2 Nantes, FR 10:00-10:10 Case presentation 2 10:10-10:25 Discussion R. Eckert 1, J. Harousseau 2 ; 1 Esslingen, DE, 2 Nantes, FR 10:25-10:30 Conclusions and future outlook J. Harousseau, Nantes, FR 10:30-11:00 Coffee break Sala B
11:00-12:00 Workshop: Management of immunotherapy related toxicity Sala B Moderation: S. Rauh, J. Haanen ; Esch Sur Alzette, LU, Amsterdam, NL 11:00-11:03 Case: Skin toxicity 11:03-11:12 Discussion J. Haanen 1, S. Rauh 2 ; 1 Amsterdam, NL, 2 Esch Sur Alzette, LU 11:12-11:15 Management proposal 11:15-11:18 Case: Hepatotoxicity 11:18-11:27 Discussion J. Haanen 1, S. Rauh 2 ; 1 Amsterdam, NL, 2 Esch Sur Alzette, LU 11:27-11:30 Management proposal 11:30-11:33 Case: Lung toxicity 11:33-11:42 Discussion J. Haanen 1, S. Rauh 2 ; 1 Amsterdam, NL, 2 Esch Sur Alzette, LU 11:42-11:45 Management proposal 11:45-11:48 Case: Endocrine or other 11:48-11:57 Discussion 11:57-12:00 Management proposal
12:00-12:30 Workshop: Allergic reactions to chemotherapy- Management including desensibilisation Sala B Moderation: H. van Halteren, Vlissingen, NL 12:00-12:20 The allergologist s contribution to chemo allergies H. van Halteren, Vlissingen, NL 12:20-12:30 Discussion 12:30-12:45 Closing remarks Sala B Moderation: 12:30-12:45 Closing remarks S. Rauh, Esch, LU 12:45-13:15 Lunch Foyer